“Surgery Following Induction (Neoadjuvant) Therapy With Pembrolizumab in Lung Adenocarcinoma With High PD-L1 Expression”. Respirar, vol. 17, no. 1, Oct. 2025, pp. 68-75, https://doi.org/10.55720/respirar.17.1.6.